Nov 6, 2009
FDA Social Media Guidance Could Do More Harm Than Good
If you are a pharmaceutical, biotech, medical device company or agency and you are not aware of the FDA hearings regarding social media guidelines, you need to pay attention, listen up, and get involved.
With all good intentions, FDA is seeking to establish guidelines around social media marketing and, given their past history of warning letters on paid search advertising, they may do more harm than good. I think Chris Schroeder from Health Central said it best by stating...
"With respect to accountability for third party content online, Americans are increasingly having conversations online that used to take place in person. Trying to make pharmaceutical and medical device companies accountable for those conversations will keep those companies from engaging consumers online. Given that the DTC advertising and other communications from the pharmaceutical and medical device companies are the only regulated part of these online conversations about health, removing such messages from will only give more space and prominence to unregulated advertisers whose products have not been approved by the FDA, which would not advance public health or promote health literacy."
Along with Chris and many others, I'll be at the FDA hearings. Discussing. Debating. And ultimately doing my very best to assist FDA in establishing guidelines that are socially responsible (pun intended), and actually improve health care as we know it.
You can follow the proceedings via my Twitter feed at twitter@roskadigital, or email me for the summary output from the proceedings.
With all good intentions, FDA is seeking to establish guidelines around social media marketing and, given their past history of warning letters on paid search advertising, they may do more harm than good. I think Chris Schroeder from Health Central said it best by stating...
"With respect to accountability for third party content online, Americans are increasingly having conversations online that used to take place in person. Trying to make pharmaceutical and medical device companies accountable for those conversations will keep those companies from engaging consumers online. Given that the DTC advertising and other communications from the pharmaceutical and medical device companies are the only regulated part of these online conversations about health, removing such messages from will only give more space and prominence to unregulated advertisers whose products have not been approved by the FDA, which would not advance public health or promote health literacy."
Along with Chris and many others, I'll be at the FDA hearings. Discussing. Debating. And ultimately doing my very best to assist FDA in establishing guidelines that are socially responsible (pun intended), and actually improve health care as we know it.
You can follow the proceedings via my Twitter feed at twitter@roskadigital, or email me for the summary output from the proceedings.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment